Slim evidence for cannabinoids for epilepsy

Epilepsy Currents

Volumn 13, Issue 2, 2013, Pages 81-82

  Miller, John W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CANNABIDIOL; CANNABINOID; CANNABIS;

ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; EPILEPSY; HUMAN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84880348276     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7597-13.2.81     Document Type: Article

References (8)

1. Gross DW, Hamm J, Ashworth NL, Quigley D. Marijuana use and epilepsy: Prevalence in patients of a tertiary care epilepsy center. Neurology 2004;62:2095-2097.
2. Keeler MH, Reifler CB. Grand mal convulsions subsequent to marijuana use: Case report. Dis Nerv Syst 1967;28:474-475.
3. Radwan MM, Elsohly MA, Slade D, Ahmed SA, Khan IA, Ross SA. Biologically active cannabinoids from high-potency Cannabis sativa. J Nat Prod 2009;72:906-911.
4. Karler R, Turkanis SA. The cannabinoids as potential antiepileptics. J Clin Pharmacol 1981;21(suppl 8-9): S437-S448.
5. Wada JA, Wake A, Sato M, Corcoran ME. Antiepileptic and prophylactic effects of tetrahydrocannabinoids in amygdaloid kindled cats. Epilepsia 1975;16:503-510.
6. Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y, Sokolovsky M. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci U S A 1989;86:9584-9587.
7. Martin P, Consroe P. Cannabinoid induced behavioral convulsions in rabbits. Science 1976;194:965-967.
8. Brust JCM, Ng SK, Hauser AW, Susser M. Marijuana use and the risk of new onset seizures. Trans Am Clin Climatol Assoc 1992;103:176-181.